Clinical Trials Management Today's Research... Tomorrow's Cures

Relationships & Accomplishments

Novartis Phase III Study Reduces Cardiovascular Risk

June 27, 2017 | Posted in: Relationships & Accomplishments
Novartis Phase III study shows ACZ885 (canakinumab) reduces cardiovascular risk in people who survived a heart attack Basel, June 22, 2017 –Novartis today announced topline results from ... » Read More


CANVAS Program

June 27, 2017 | Posted in: Relationships & Accomplishments
RE: CANVAS Program main results We were excited to report the CANVAS Program main results at the recent meeting of the American Diabetes Assoc... » Read More


AMAG Pharmaceuticals, Inc.

May 31, 2017 | Posted in: Relationships & Accomplishments
WALTHAM, Mass., May 2, 2017 – AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced positive top-line results from a Phase 3 randomized, double-blind, non-inferiority clinical trial evalua... » Read More


Viamet Reports Positive Results from REVIVE

May 31, 2017 | Posted in: Relationships & Accomplishments
Viamet Reports Positive Results from REVIVE Phase 2b Trial of Oral VT-1161 in Recurrent Vulvovaginal Candidiasis -48 Week Results Demonstrate Strong Clinical Benefit and Very Favorable Safet... » Read More